Medicare Coverage For CAR-T Will Require Additional Patient Data Collection

Draft national coverage decision addresses current indications and hospital sites of care. CMS expects to “leverage” existing FDA post-market data collection requirements but seeks additional data on patient-reported outcomes in some cases.